Vertex Pharmaceuticals Incorporated shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $32M | 67k | 468.72 |
| 2024-03-31 | $50M | 119k | 418.01 |
| 2023-12-31 | $28M | 68k | 406.89 |
| 2023-09-30 | $1.8M | 5.1k | 347.74 |
| 2023-06-30 | $1.4M | 3.9k | 351.91 |
| 2023-03-31 | $1.6M | 5.1k | 315.07 |
| 2022-12-31 | $3.2M | 11k | 288.78 |
| 2022-09-30 | $8.2M | 28k | 289.54 |
| 2022-06-30 | $17M | 60k | 281.79 |
| 2022-03-31 | $7.9M | 30k | 260.96 |
| 2021-12-31 | $4.9M | 22k | 219.58 |
| 2021-09-30 | $4.5M | 25k | 181.39 |
| 2021-06-30 | $3.7M | 19k | 201.60 |
| 2021-03-31 | $4.8M | 22k | 214.89 |
| 2020-12-31 | $6.0M | 26k | 236.35 |
| 2020-09-30 | $15M | 53k | 272.12 |
| 2020-06-30 | $27M | 92k | 290.31 |
| 2020-03-31 | $23M | 97k | 237.95 |
| 2019-12-31 | $11M | 51k | 218.94 |
| 2019-09-30 | $2.3M | 14k | 169.40 |
| 2019-06-30 | $2.4M | 13k | 183.40 |
| 2019-03-31 | $1.9M | 10k | 183.92 |
| 2018-12-31 | $1.1M | 6.6k | 165.76 |
| 2018-09-30 | $5.5M | 29k | 192.75 |
| 2018-06-30 | $7.2M | 42k | 169.97 |
| 2018-03-31 | $1.8M | 11k | 163.01 |
| 2017-12-31 | $2.0M | 13k | 149.87 |
| 2017-09-30 | $2.0M | 13k | 152.06 |
| 2017-06-30 | $1.3M | 10k | 128.90 |
| 2017-03-31 | $459k | 4.2k | 109.29 |
| 2016-03-31 | $533k | 6.7k | 79.55 |
| 2015-12-31 | $528k | 4.2k | 125.71 |
| 2015-09-30 | $969k | 9.3k | 104.19 |
| 2014-06-30 | $2.6M | 26k | 100.86 |
| 2014-03-31 | $18M | 228k | 78.06 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated